2025 ASCO Annual Meeting
Join Fortrea at ASCO 2025!
Meet us in Chicago May 30-June 3 at booth 14137 as we take part in the most significant gathering of oncology professionals worldwide.
While at ASCO, we invite you to meet with our team of clinical trial experts who will be on hand to discuss the needs of your pipeline. We look forward to sharing our knowledge and experience to aid the development of your cancer therapeutics from early stage trials all the way through post-approval studies. Our goal is to accelerate your progress through a collaborative approach. Stop by the booth and connect with our subject matter experts. We look forward to connecting with you!
For more information about ASCO 2025, please visit: https://conferences.asco.org/am/attend
Fortrea is proud to partner with #GildasClubChicago to create and distribute care packages at cancer centers across the Chicagoland area.
Stop by booth 14137 at #ASCO25 to build and personalize your care package for a pediatric, teen, or adult patient, then follow along after the conference as they’re delivered.
Learn more about how Gilda’s Club is supporting the Chicago community: https://www.gildasclubchicago.org/
- Sinai Chicago (Mount Sinai Hospital and Holy Cross Hospital)
- Ascension Saint Mary Chicago
- Ann & Robert H. Lurie Children’s Hospital
- Ascension Saint Joseph - Chicago
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- Advocate Children’s Hospital
- Advocate Christ Medical Center and the Gilda's Club Chicago satellite clubhouse at Advocate Christ Medical Center
- Gilda's Club Chicago Downtown Clubhouse
Proudly Showcasing Our Contributions to ASCO 2025
We are honored to share that several of our abstracts have been accepted for presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting 2025. These selections highlight our continued commitment to advancing oncology research and delivering meaningful outcomes for patients worldwide.
ASCO 2025 | Abstract
Systematic review of BCMA-targeted advanced therapies in relapsed/refractory multiple myeloma.
Judith Pérez-Granado, Kamal S. Saini, Carmen Besliu, Abhishek Shankar, Laura Vidal, Bruno Larvol, Mark Gramling.
https://www.asco.org/abstracts-presentations/ABSTRACT495512
ASCO 2025 | Poster
Unveiling the differences in tumor immune microenvironment between KRAS-wildtype and KRAS-mutant pancreatic ductal adenocarcinoma.
Heidi Chwan Ko, RJ Seager, Maria-Fernanda Senosain, Hardik Parikh, Erik Van Roey, Shuang Gao, Yamuna Pulivendula, Paul DePietro, Stuti Patel, Michelle Green, Kyle C. Strickland, Rebecca Ann Previs, Erin Newburn, Kamal S. Saini, Alicia Dillard, Eric Severson, Brian Caveney, Taylor J. Jensen, Shakti Ramkissoon, Sarabjot Pabla.
https://www.asco.org/abstracts-presentations/ABSTRACT488474
ASCO 2025 | Abstract
Systematic review of 2L+ ADC strategies in TNBC.
Judith Pérez-Granado, Kamal S. Saini, Luca Cantini, Shakti Ramkissoon, Heidi Ko, Laura Vidal, Isagani Chico, Bruno Larvol, Mark Gramling.
https://www.asco.org/abstracts-presentations/ABSTRACT494188
